Topic: European Commission
BRUSSELS (Reuters) - A European Union court backed an EU antitrust decision against Anglo-Swedish drugmaker AstraZeneca Thursday, lending weight to a regulatory crackdown on firms blocking cheaper drugs coming to market. Antitrust lawyers said the ruling set a firm legal precedent for ...
The European Commission on Tuesday approved the cultivation of genetically-modified potatoes, prompting an angry response from environmental campaign groups and two EU member governments. Austria said it was planning an immediate ban on the potatoes' cultivation, while Italy's agriculture minister slammed the ...
Swiss pharmaceutical giant Novartis said on Wednesday that offices of its subsidiary Sandoz were raided by European Commission investigators probing suspected competition violations. "The French offices of Sandoz were raided" on Tuesday, a Novartis spokesman said, without giving further details. He added ...
The European Union warned Wednesday of a wave of antitrust investigations into major drugmakers, saying they were deliberately stalling cheaper generic versions of their own medicines once exclusive patents expire. "Makers of original medicines are actively trying to delay the entry of ...
The European Union's competition regulator launched a probe into the pharmaceutical sector Wednesday over concerns that cheap generic medicines are not reaching patients in need. The move came after a sector-wide report showed that the number of new drugs reaching the market ...
The EU's competition services will examine US drug manufacturer Pfizer Inc's takeover of rival Wyeth, the largest pharmaceutical takeover deal in nearly a decade, the European Commission announced Tuesday. The EU Commission will give its opinion on July 6 on whether the ...
EU food safety agency panel approves 2 genetically modified corn productsThe European Union's food safety agency approved two genetically modified corns Friday, putting renewed pressure on EU nations to drop their objections to the use of biotech crops. Scientists at the Parma, ...
The NHS's £11bn annual bill for drugs could soar if pharmaceutical companies are allowed to start pushing promotional 'information' about their products directly to patients, claim health and consumer groups. The European Union will next month unveil plans to let drug firms ...